IDH1 and central nervous system cancer: Mutant IDH1 anaplastic astrocytomas, glioblastomas and oligodendroglial tumors have independent favorable prognostic factor particularly for grade III gliomas, and usually associated with increased progression-free survival and overall survival and may exceed other genetic markers.